BridgeMD
New treatment option for Elevated Pulmonary Artery Pressure
Official title Telerehabilitation in Patients With Elevated Pulmonary Artery Pressure
ClinicalTrials.gov ID: NCT07535398
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if synchronous telerehabilitation is effective in patients with elevated pulmonary artery pressure identified by echocardiography (systolic pulmonary artery pressure ≥50 mmHg). It will also evaluate the effects of telerehabilitation on exercise capacity, dyspnea, fatigue, functional status, and quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18 to 65 years
- Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
- Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
- New York Heart Association (NYHA) functional class I or II
- Living with a caregiver, family member, or another person who can provide assistance if needed
You likely can't join if
- Requirement for oxygen therapy
- Musculoskeletal problems limiting participation in exercise
- Ongoing treatment for psychiatric or psychological disorders
- Cognitive impairment based on Mini-Mental State Examination findings
- Severe chronic obstructive pulmonary disease (COPD)
- Other significant cardiac disease that may interfere with participation or assessment
See the full eligibility criteria
- Adults aged 18 to 65 years
- Elevated pulmonary artery pressure identified by echocardiography, defined as systolic pulmonary artery pressure (sPAP) of 50 mmHg or higher
- Clinically stable and receiving medical treatment under cardiology follow-up World Health Organization functional class I or II
- New York Heart Association (NYHA) functional class I or II
- Living with a caregiver, family member, or another person who can provide assistance if needed
- Access to the internet and adequate visual, cognitive, and functional ability to participate in videoconference-based sessions
- Willing to participate and able to provide informed consent
- Requirement for oxygen therapy
- Musculoskeletal problems limiting participation in exercise
- Ongoing treatment for psychiatric or psychological disorders
- Cognitive impairment based on Mini-Mental State Examination findings
- Severe chronic obstructive pulmonary disease (COPD)
- Other significant cardiac disease that may interfere with participation or assessment
The study team makes the final eligibility decision.
Where it's taking place
- Tokat Province, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tokat Province, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.